Tab. 2 – Dávkování léčiv při chronickém selhání ledvin a chronické renální insuficienci (úprava dávkovacího intervalu h, nebo % dávky) | |||||
Léčivo | Renální | GF > 50 | GF 10–50 | GF < 10 | Poznámka |
exkrece (%) | (ml/min) | (ml/min) | (ml/min) | ||
ACE-inhibitory | 50–70 | N | 50–75 % | 25–50 % | hyperkalémie, NÚL |
Acebutolol | 55 | N | 50 % | 25 % | aktivní metabolity |
Acetazolamid | 100 | 6 | 12 | nepodávat | metabolická acidóza |
Acetylsalicylová kyselina | 10 | 4 | 4–6 | nepodávat | |
Acyklovir (i. v.) | 40–70 | 6 | 24 | 48 | |
Alendronát sodný | 50 | N | nepodávat | nepodávat | |
Allopurinol | 50 | N | 50 % | 10–25 % | NÚL |
Amantadin | 90 | 12–24 | 24–72 | 72–168 | |
Amfotericin B | 5 | 24 | 24 | 24–36 | poškození ledvin |
Amilorid | 50 | 12–24 | nepodávat | nepodávat | hyperkalémie |
Aminoglykosidy | > 90 | 8–12 | 12 | > 24 | monitorování hladin |
Amoxicilin | 86 | 8 | 8–12 | 12–24 | |
Ampicilin | 82 | 6 | 6–12 | 12–16 | |
Atenolol | < 90 | N | 50 % | 25 % | |
Aztreonam | 75 | N | 50-75 % | 25 % | |
Betaxolol | 15 | N | N | 50 % | |
Bretylium | 75 | N | 25–50 % | nepodávat | |
Cefadroxil | 70–90 | 12 | 12–24 | 24–48 | |
Cefalexin | 90 | 6 | 6 | 8–12 | |
Cefalotin | 60–90 | 6 | 6–8 | 12 | |
Cefazolin | 80 | 8 | 12 | 24–48 | |
Cefepim | 80 | 12 | 24 | 25 %, 24 h | |
Cefixim | 20–50 | 12–24 | 75 % | 50 % | |
Cefotaxim | 50–60 | 6–8 | 8–12 | 24 | |
Cefoxitin | 77–90 | 8 | 8–12 | 24–48 | |
Cefpodoxim | 30 | 12 | 16 | 24–48 | |
Ceftazidim | 60 | 8–12 | 24–48 | 48–72 | |
Ceftriaxon | 30–65 | N | N | 24 | |
Cefuroxim | > 90 | N | 12 | 24 | |
Cetirizin | 50 | N | 50 % | 50 % | |
Cimetidin | 40–70 | 6 | 8 | 12 | |
Ciprofloxacin | 50–70 | N | 12–24 | 24 | |
Didanosin | 40 | 12 | 24 | 48 | |
Digoxin | 76–85 | 24 | 36 | 48 | monitorování hladin |
Disopyramid | 50–60 | 75 % | 25–50 % | 10–25 % | |
Doxycyklin | 33–45 | 12 | 12–18 | 18 24 | kumulace metabolitů |
Ethambutol | 75–90 | 24 | 24–36 | 48 | |
Ethosuximid | N | N | 75% | ||
Famcyklovir | metabolit | 8 | 12–24 | 48 | |
Famotidin | 80 | N | N | 50 % | |
Fenobarbital | N | N | 12-16 | ||
Flucytosin | > 90 | 6 | 24 | 24-48 | |
Flukonazol | 70 | N | 50 % | 25 % | |
Gancyklovir | 95–100 | 12 | 24 | 24 | |
Gemfibrozil | < 10 | N | 50 % | 25 % | |
Hydralazin (p. o.) | 25 | 8 | 8 | 8–16 | |
Hydrochlorothiazid | > 95 | N | N | nepodávat | |
Chlortalidon | 50 | 24–48 | nepodávat | nepodávat | |
Imipenem | 20–70 | N | 50 % | 25 % | |
Indapamid | 7 | N | N | nepodávat |